The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-70
SponsorUniversity of California, Davis
About this trial
Recently a dietary recommendation of 400 - 600 mg/ day has been proposed for the reduced risk of developing cardiovascular disease. Dietary flavanols can be obtained from the intake of foods such as tea, cocoa, wine, berries and apples. Incorporating Chardonnay Marc (the skins and seeds of Chardonnay grapes) into the diet can be an additional source of dietary flavanols. Like other flavanol-rich foods, Chardonnay Marc provides fiber and polysaccharides that may benefit gut health. This study seeks pilot data on the impact of the daily incorporation of Chardonnay Marc powder into the diet on markers of gut and cardiometabolic health.
Eligibility criteria
Qualifiers
Postmenopausal female, with a cessation of menses for at least 2 years
45-70 years of age
BMI 25- 49.9 kg/m2
Fasting triglycerides > 120 mg/dL
Disqualifiers
Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
Prescription medications and supplements, except for a 6 month stable dose of thyroid medications
Vegan, Vegetarians, food faddists or those consuming a non-traditional diet
Fruit consumption ≥ 3 cups/day
Trial design
Treatments tested in this trial
- Chardonnay Marc
Treatment groups
5 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov